STAT+: FDA approves Replimune melanoma drug previously rejected twice
STAT News · LC · trust 39/100
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.
Read the original at STAT News →
Open in TruthVane →